###### Strengths and limitations of this study

-   Our study is the first to examine the validity of lipid accumulation product (LAP), which is calculated using a modified formula, in the Southern Chinese population.

-   This is a cross-sectional study; the results are not sufficient to indicate causality.

-   The population of our study can partially represent the general population in the Southern China but cannot fully represent this region.

-   This study lacks the adjustment for renal function, and other risk factors for hypertension (such as serum uric acid).

-   This study has a small sample size, so further studies with a larger sample size are needed to investigate whether the modified LAP applies to all the residents dwelling in Southern China.

Introduction {#s1}
============

Hypertension, a significant risk factor of cardiovascular disease,[@R1] is one of the most prevalent public health problems in the world and is the leading contributor to the global burden of disease and mortality. Nowadays, the number of adults with hypertension in the world is being predicted to increase by about 60% to a total of 1.56 billion in 2025, and one-third of adults are suffering from hypertension in China.[@R2]

Obesity, especially visceral fat, and family history of hypertension contribute to hypertension significantly.[@R4] Numerous studies agree on the idea that people with family history of hypertension have higher chance to get hypertension.[@R6] Usually, when it comes to obesity, the indexes that are most frequently used to assess obesity are body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR); however, these traditional obesity indexes merely reflect the degrees of overweight and abdominal obesity, and also cannot distinguish the difference between subcutaneous fat and visceral fat.[@R10] Micro-MRI and micro-CT, which are the golden standard measurement methods of visceral fat, are inconvenient and expensive.[@R11] Moreover, they are not suitable for large-scale epidemiological investigations. Therefore, it is necessary to discover a new obesity indicator that can predict visceral fat from subcutaneous fat more conveniently and economically.

Recently, increasing attention has been directed towards lipid accumulation product (LAP). LAP, a new obesity index computed from WC and triglyceride (TG), is a useful indicator of visceral fat,[@R12] as demonstrated by Kahn in 2005.[@R13] Some studies suggest that LAP can also be used to identify metabolic syndromes,[@R14] type 2 diabetes mellitus,[@R16] stroke[@R17] and arterial stiffness.[@R18] Additionally, several cross-sectional studies conducted in Japan,[@R19] India[@R14] and Brazil indicate that LAP significantly associated with cardiovascular disease and is a better indicator than BMI for identifying cardiovascular risk.[@R13] A few national studies have investigated the association between LAP and hypertension in China, and all of them are conducted in Northern China, including Bengbu,[@R21] Beijing[@R22] and Inner Mongolia.[@R23] With a vast territory, China has a tremendous difference between South and North. Due to the geographical environment and dietary habits that have formed throughout its long history, there are some dietary and cultural differences between Northern and Southern China.[@R24] The northern region shows a high intake of wheat, tubers, liquor, and so on, while southerners have a high intake of rice, vegetables, meat, poultry, fish, and so on.[@R24] The carbohydrate-rich pattern of the northern region is associated with a high risk of hypertriglyceridaemia and higher BMI. Meanwhile, significant differences are found in systolic blood pressure (SBP)/diastolic blood pressure (DBP) between Southern Chinese and Northern Chinese owing to different climate and dietary habits between Southern and Northern.[@R25] Studies have found that the northerners are heavier and have higher TG level than southerners.[@R26] The different dietary habits and lifestyle indirectly causes the different of LAP in the North and South. Thus, the applicability of LAP in predicting hypertension in Southern China is worth studying. However, rare studies have compared LAP with other obesity indexes in the Southern Chinese population. Besides, almost all studies about LAP are using the formula based on the third National Health and Nutrition Examination Survey in the USA. Therefore, it is reasonable to suggest that the calculation formula of LAP needs to be modified in the Chinese population.

To the best of our knowledge, no studies have attempted to adjust the calculation formula of LAP so that it can apply to the Southern Chinese population, and rare studies have explored additive interactions between family history of hypertension and LAP. Thus, the primary purpose of this study is to investigate the applicability of LAP in the Southern Chinese population and compare the predictive effects of LAP and other obesity indicators on hypertension risk. The secondary purpose of the study is to assess the interactive effects between LAP and family history of hypertension to predict the hypertension risk in the Southern Chinese population.

Methods {#s2}
=======

Study design and subjects {#s2-1}
-------------------------

A cross-sectional survey based on community health was conducted in the Foshan city of Guangdong province in Southern China. Recruiting the enrollers took place in March 2017. The study samples were selected by a multistage and stratified random sampling method. The stratification according to the economic levels and randomly selected urban and rural at economic levels, then randomly selected communities in urban and rural according to proportion. Community residents were then randomly selected from the household lists. A total of 3760 individuals were enrolled in this study; among them, 1681 participants who lacked complete data on demographic characteristics, anthropometric tests, or laboratory examinations were excluded. There were no statistically significant differences in age and sex between excluded participants and included participants. Finally, 2079 adults who had complete data were included in the analysis.

Patient and public involvement {#s2-2}
------------------------------

Patients or public were not involved in this study.

General study questionnaire {#s2-3}
---------------------------

An interview-based survey was performed using a questionnaire by trained staff. Sociodemographic data, family history of hypertension, cigarette smoking and alcohol drinking were investigated. Smokers were defined as the participants smoking at least one cigarette/day for at least 6 months. Drinkers were defined as individuals consuming at least 30 mL alcohol/week for 1 year or more. Physical activities were divided into 'insufficiently active' and 'sufficiently active'. Participants with 'insufficiently active' physical activities were defined as those who performed activity less than 150 min/week. Participants with 'sufficiently active' physical activities were defined as those who exercised more than 150 min/week.[@R28] Marital status was classified as 'currently not married' and 'currently married'; 'married' was regarded as 'currently married', and 'divorced/widowed/single' was regarded as 'currently not married'. Educational level was categorised as 'elementary school or lower', 'secondary school' and 'senior high school or higher'.

Anthropometric tests and laboratory examinations {#s2-4}
------------------------------------------------

The participants were required to take off their shoes and wear lightweight clothing for weight and height measurements. WC was measured at the level of 1 cm above the navel.[@R29] Automatic sphygmomanometer (OMRON, hem-7125) was used to measure blood pressure (BP) of participants. BP measurement was conducted thrice in a quiet environment, and the participants rested at least 1 min between each time of measurement. The mean of the three measurements was used in the analysis. Prehypertension was defined as SBP 120--139 mm Hg and/or DBP 80--89 mm Hg, and hypertension was defined as SBP≥140 mm Hg, DBP≥90 mm Hg and/or a reported medical history of antihypertensive medication.[@R29] The BMI was calculated as weight in kilograms divided by the square of the height in metres. Overweight was defined as BMI 24--27.9 kg/m^2^, and obesity was defined as BMI≥28 kg/m^2^. The fasting blood samples were collected from the participants in the morning after an overnight fast and were used to assess fasting plasma glucose, total cholesterol and TG levels.

According to Kahn's theory,[@R13] LAP is calculated as \[WC (cm) − the minimum of WC (male)\] × \[TG (mmol/L)\] for males and \[WC (cm) − the minimum of WC (female)\] × \[TG (mmol/L)\] for females, and the minimum waist size theoretically contains only the abdomen, muscle, viscera and vertebral bone.[@R13] Visceral fat can be estimated by the difference between the WC and the minimum waist size. In the present study, the WC of the studied population was skewed; therefore, the WC was log transformed. The minimum WC was estimated by the mean WC minus 2 SDs after log transformation in the local participants aged 18--24 years.[@R13]

Statistical analyses {#s2-5}
--------------------

According to the hypertension status, the enrollees were divided into three groups (normotension, prehypertension and hypertension). The frequency (%) was used to describe sex, marital status, education level, physical activity, BMI, smoker and drinker. Mean±SD was used to describe the WC, WHR, fasting plasma glucose, total cholesterol, TG, SBP, DBP and LAP. LAP was divided into four groups by the quartiles, that is, Q1, Q2, Q3 and Q4. The differences of quantitative data across different hypertension statuses were analysed by the Kruskal-Wallis H test because the data had skewed distribution. Categorical variables were analysed by the χ^2^ test. The multivariate logistic regression model was used to analyse the relationship between LAP and risk factors of hypertension and prehypertension. The receiver operating characteristic (ROC) curves were applied to identify the superior obesity index and the best cut-off value of LAP to predict the hypertension risk. Moreover, the interaction effects between LAP and family history of hypertension were assessed by some relevant indicators, including the relative excess risk of interaction (RERI=OR~11~−OR~10~−OR~01~+1), the attributable proportion due to interaction (AP=\[OR~11~−OR~10~−OR~01~+1\]/OR~11~) and the synergy index (SI=\[OR~11~−1\]/\[OR~01~−1\]+\[OR~10~−1\]). If the interaction effect was not observed, the CI of RERI and AP contained 0 and the CI of SI included 1.[@R30] The above indicators were calculated using an Excel table designed by Andersson *et al*.[@R30] All reported p values were two tailed, and a p value \<0.05 was considered significant. Statistical analyses were performed using SPSS V.19.0 (SPSS).

Results {#s3}
=======

Lipid accumulation product {#s3-1}
--------------------------

According to Kahn's theory,[@R13] LAP was calculated as (WC−60.6)×(TG \[mmol/L\]) in males and (WC−54.1)×(TG \[mmol/L\]) in females based on the actual data obtained from the Southern Chinese population.[@R22]

Basic characteristics of the study participants {#s3-2}
-----------------------------------------------

A total number of 2079 of adults with an average age of 41.06 years were enrolled in the present study, including 1002 males (48.20%) and 1077 females (51.80%). The overall prevalence rates of normotension, prehypertension and hypertension were 40.02%, 37.95% and 22.03%, respectively. Male participants had a high prevalence of prehypertension and hypertension than female participants (p\<0.001). Statistically significant differences in age (p\<0.001), marital status (p\<0.001), education level (p\<0.001), smoker (p\<0.001), drinker (p\<0.001) and family history of hypertension (p=0.005) were observed between normotension, prehypertension and hypertension groups. However, no significant differences were observed in physical activity (p=0.611\>0.05) among the three groups. Anthropometric measurements found significant differences in BMI (p\<0.001), WC (p\<0.001), WHR (p\<0.001) and LAP (p\<0.001) between the groups. Statistically significant differences were found in laboratory examinations including fasting plasma glucose (p\<0.001), total cholesterol (p\<0.001), SBP (p\<0.001) and DBP (p\<0.001) between the groups ([table 1](#T1){ref-type="table"}). The basic characteristics of different sex of study participants were shown in [table 2](#T2){ref-type="table"}.

###### 

Basic characteristics of the participants

  ------------------------------------------------------------------------------------------------------------
  Variables                            Normotension\   Prehypertension\   Hypertension\   χ^2^/Z     P value
                                       (n=832)         (n=789)            (n=458)                    
  ------------------------------------ --------------- ------------------ --------------- ---------- ---------
  Sex (%)                                                                                 135.625    \<0.001

   Male                                32.57           58.68              58.52                      

   Female                              67.43           41.32              41.48                      

  Age (years)                          36.42±10.59     41.38±12.71        48.93±12.75     267.206    \<0.001

  Marital status (%)                                                                      21.287     \<0.001

   Currently not married               23.20           18.76              12.66                      

   Currently married                   76.80           81.24              87.34                      

  Education level (%)                                                                     101.355    \<0.001

   Elementary school and lower         15.87           21.55              36.46                      

   Secondary school                    36.30           38.53              39.96                      

   Senior high school and higher       47.83           39.92              23.58                      

  Physical activity (%)                                                                   2.688      0.611

   Seldom or never                     35.70           34.22              31.22                      

   Moderate                            17.43           18.25              18.78                      

   High                                46.87           47.53              50.00                      

  Smoker (%)                                                                              50.346     \<0.001

   Non-smoker                          82.25           71.61              67.90                      

   Smoker                              16.18           26.87              28.61                      

   Former smoker                       0.97            1.52               3.49                       

  Drinker (%)                                                                             30.865     \<0.001

   Non-drinker                         84.11           76.34              72.53                      

   Drinker                             14.91           22.39              24.62                      

   Former drinker                      0.98            1.27               2.85                       

  BMI                                                                                     255.012    \<0.001

   \<18.5                              13.70           5.20               2.18                       

   18.5--23.9                          68.51           54.88              41.70                      

   24--27.9                            14.30           31.69              37.55                      

   ≥28                                 3.49            8.24               18.56                      

  WC                                   75.61±8.19      81.61±9.04         87.02±9.95      411.441    \<0.001

  WHR                                  0.85±0.06       0.88±0.07          0.91±0.06       248.475    \<0.001

  Fasting plasma glucose (mmol/L)      4.69±0.82       4.98±1.33          5.31±1.86       90.399     \<0.001

  Total cholesterol (mmol/L)           4.70±0.96       4.98±1.07          5.26±1.15       88.325     \<0.001

  Triglyceride (mmol/L)                1.26±0.83       1.77±1.77          2.15±2.25       178.995    \<0.001

  Systolic blood pressure (mm Hg)      107.97±7.80     125.45±6.65        144.78±18.55    1533.137   \<0.001

  Diastolic blood pressure (mm Hg)     69.49±6.40      79.59±5.99         91.49±11.33     1206.505   \<0.001

  Family history of hypertension (%)                                                      18.391     0.005

   Only father                         11.42           11.03              11.14                      

   Only mother                         12.02           15.08              17.25                      

   Both parents                        5.41            4.82               8.95                       

   Neither                             71.15           69.07              62.66                      

  LAP                                  29.14±27.00     52.15±63.50        75.87±99.81     355.133    \<0.001
  ------------------------------------------------------------------------------------------------------------

BMI, body mass index; LAP, lipid accumulation product; WC, waist circumference; WHR, waist-to-hip ratio.

###### 

Basic characteristics of the participants

  Variables                            Male          Female                                                                                                
  ------------------------------------ ------------- ------------- -------------- --------- --------- ------------- ------------- -------------- --------- ---------
  Age (years)                          36.57±11.02   39.90±12.37   47.15±12.95    91.532    \<0.001   36.35±10.39   43.48±12.92   51.43±12.11    201.378   \<0.001
  Marital status (%)                                                              26.019    \<0.001                                              7.928     0.019
   Currently not married               31.37         22.46         13.06                              19.25         13.50         12.11                    
   Currently married                   68.63         77.54         86.94                              80.75         86.50         87.89                    
  Education level (%)                                                             24.179    \<0.001                                              116.258   \<0.001
   Elementary school and lower         15.13         15.33         25.00                              16.22         30.37         52.63                    
   Secondary school                    37.64         40.39         45.15                              35.65         35.89         32.63                    
   Senior high school and higher       47.23         44.28         29.85                              48.13         33.74         14.74                    
  Physical activity (%)                                                           0.807     0.668                                                2.979     0.226
   Insufficiently active               58.30         56.16         54.48                              50.62         47.24         43.68                    
   Sufficiently active                 41.70         43.84         45.52                              49.38         52.76         56.32                    
  Smoker (%)                                                                      7.037     0.132                                                5.893     0.122
   Non-smoker                          47.78         52.27         46.27                              99.82         99.08         99.42                    
   Smoker                              49.26         45.36         48.13                              0.18          0.61          1.05                     
   Former smoker                       2.96          2.38          5.60                               0.00          0.31          0.53                     
  Drinker (%)                                                                     3.790     0.432                                                4.993     0.255
   Non-drinker                         60.74         61.47         57.30                              95.62         97.53         94.15                    
   Drinker                             36.67         36.36         38.20                              4.20          2.47          5.32                     
   Former drinker                      2.59          2.16          4.49                               0.18          0.00          0.53                     
  BMI                                                                             148.700   \<0.001                                              99.205    \<0.001
   \<18.5                              16.61         4.54          1.49                               12.30         6.13          3.16                     
   18.5--23.9                          65.68         54.64         38.43                              69.88         55.21         46.32                    
   24--27.9                            14.39         33.26         39.18                              14.26         29.45         35.26                    
   ≥28                                 3.32          7.56          20.90                              3.57          9.20          15.26                    
  WC                                   77.26±7.85    82.95±8.49    88.71±9.43     193.623   \<0.001   74.82±8.24    79.72±9.46    84.63±10.20    154.819   \<0.001
  WHR                                  0.86±0.06     0.89±0.06     0.92±0.06      126.195   \<0.001   0.84±0.07     0.86±0.07     0.89±0.06      183.524   \<0.001
  Fasting plasma glucose (mmol/L)      4.76±1.08     4.98±1.38     5.30±1.94      24.275    \<0.001   4.65±0.66     4.99±1.26     5.31±1.75      71.169    \<0.001
  Total cholesterol (mmol/L)           4.73±1.00     4.98±1.06     5.17±1.25      20.500    \<0.001   4.69±0.94     4.98±1.08     5.39±0.98      73.075    \<0.001
  Triglyceride (mmol/L)                1.54±1.08     1.93±1.94     2.38±2.68      40.974    \<0.001   1.12±0.64     1.54±1.47     1.82±1.40      90.583    \<0.001
  Systolic blood pressure (mm Hg)      110.52±6.13   125.60±6.54   145.64±17.04   706.430   \<0.001   106.73±8.21   125.23±6.81   143.57±20.48   755.356   \<0.001
  Diastolic blood pressure (mm Hg)     70.82±5.79    80.27±5.75    93.11±10.66    592.747   \<0.001   68.84±6.59    78.63±6.19    89.20±11.87    553.348   \<0.001
  Family history of hypertension (%)                                              16.427    0.012                                                6.847     0.335
   Only father                         10.70         11.23         13.81                              11.76         10.74         7.37                     
   Only mother                         11.44         17.28         18.28                              12.30         11.96         15.79                    
   Both parents                        6.27          4.75          9.70                               4.99          4.91          7.89                     
   Neither                             71.59         66.74         58.21                              70.94         72.39         68.95                    
  LAP                                  38.69±34.85   58.43±65.52   87.83±120.94   113.508   \<0.001   24.52±20.75   43.24±59.48   58.98±54.19    159.320   \<0.001

BMI, body mass index; LAP, lipid accumulation product; WC, waist circumference; WHR, waist-to-hip ratio.

LAP and the risk factors of hypertension {#s3-3}
----------------------------------------

In order to investigate the relationship between LAP and BP, LAP was divided into four groups by quartile in different sex ([table 3](#T3){ref-type="table"}). A significant association was observed between LAP and BP in both males and females. The results in males and females showed that SBP (p\<0.001) and DBP (p\<0.001) were relatively elevated in participants with higher LAP levels.

###### 

Comparison of blood pressure among four quartiles of LAP

  Variables                           LAP            Z              P value                                 
  ----------------------------------- -------------- -------------- -------------- -------------- --------- ---------
  Male                                                                                                      
   Systolic blood pressure (mm Hg)    119.33±13.72   125.61±14.86   129.23±16.38   133.36±17.85   106.793   \<0.001
   Diastolic blood pressure (mm Hg)   75.84±9.89     80.55±9.84     82.56±10.74    85.64±11.36    106.285   \<0.001
  Female                                                                                                    
   Systolic blood pressure (mm Hg)    110.45±13.91   114.95±15.07   119.66±15.91   130.25±19.78   184.926   \<0.001
   Diastolic blood pressure (mm Hg)   71.05±9.45     73.29±9.60     76.21±9.96     81.04±11.70    134.730   \<0.001

LAP, lipid accumulation product.

Multinomial logistic regression analysis was conducted to evaluate the association between LAP quartiles and hypertension status ([table 4](#T4){ref-type="table"}). Participants with the third and the fourth quartiles of LAP were more likely to develop prehypertension and hypertension than those with the first quartile in both males and females.

###### 

Multinomial logistic regression analysis of LAP associated with hypertension status

  ---------------------------------------------------------------------------------------------------------------------------
  Quartiles of LAP   OR (95% CI)†     OR (95% CI)‡       OR (95% CI)§                                        
  ------------------ ---------------- ------------------ ---------------- ----------------- ---------------- ----------------
  Male                                                                                                       

   Q1                1 (reference）   1 (reference）     1 (reference）   1 (reference）    1 (reference）   1 (reference）

   Q2                2.98\*\*\*\      4.70\*\*\*\        2.22\*\*\*\      2.38\*\*\         1.73\*\          1.61\
                     (1.88 to 4.72)   (2.34 to 9.45)     (1.48 to 3.34)   (1.36 to 4.16)    (1.12 to 2.67)   (0.89 to 2.94)

   Q3                4.48\*\*\*\      8.26\*\*\*\        2.68\*\*\*\      3.90\*\*\*\       1.66\*\          1.75\
                     (2.85 to 7.03)   (4.21 to 16.21)    (1.74 to 4.12)   (2.24 to 6.82)    (1.03 to 2.68)   (0.94 to 3.26)

   Q4                4.65\*\*\*\      17.82\*\*\*\       3.14\*\*\*\      9.02\*\*\*\       1.67\            2.79\*\*\*\
                     (2.93 to 7.36)   (9.21 to 34.46)    (1.95 to 5.07)   (5.11 to 15.93)   (0.96 to 2.92)   (1.43 to 5.44)

  Female                                                                                                     

   Q1                1 (reference）   1 (reference）     1 (reference）   1 (reference）    1 (reference）   1 (reference）

   Q2                1.75\*\*\        2.19\*\*\          1.046\           1.19\             0.91\            1.015\
                     (1.22 to 2.51)   (1.27 to 3.77)     (0.69 to 1.58)   (0.62 to 2.29)    (0.59 to 1.41)   (0.51 to 2.03)

   Q3                3.35\*\*\*\      6.50\*\*\*\        1.68\*\*\        1.87\             1.31\            1.19\
                     (2.27 to 4.93)   (3.83 to 11.02)    (1.11 to 2.52)   (0.99 to 3.49)    (0.84 to 2.05)   (0.60 to 2.38)

   Q4                5.99\*\*\*\      20.06\*\*\*\       3.26\*\*\*\      6.32\*\*\*\       2.10\*\*\        3.15\*\*\*\
                     (3.74 to 9.59)   (11.37 to 35.38)   (2.09 to 5.10)   (3.42 to 11.65)   (1.26 to 3.51)   (1.56 to 6.39)
  ---------------------------------------------------------------------------------------------------------------------------

\*P\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.

†Unadjusted.

‡Adjusted for age, sex, marital status and educational level.

§Adjusted for physical activity, smoker, drinker, body mass index (BMI), waist-to-hip ratio (WHR), fasting plasma glucose, family history of hypertension and all the factors in ‡.

After adjusting for age, marital status and educational level, the risks of prehypertension (adjusted OR: 3.14, 95% CI 1.95 to 5.07) and hypertension (adjusted OR: 9.02; 95% CI 5.11 to 15.93) significantly increased in male participants with the fourth quartile compared with those with the first quartile. For females, increasing risks of prehypertension (adjusted OR: 3.26, 95% CI 2.09 to 5.10) and hypertension (adjusted OR: 6.32; 95% CI 3.42 to 11.65) were observed in participants with the fourth LAP quartile compared with those with the first one.

After controlling for age, marital status, educational level, physical activity, smoking, alcohol consumption, BMI, WHR, fasting plasma glucose and family history of hypertension, the risks of prehypertension (adjusted OR: 1.67, 95% CI 0.96 to 2.92) and hypertension (adjusted OR: 2.79, 95% CI 1.43 to 5.44) significantly increased in male participants with the fourth quartile compared with those with the first quartile. Meanwhile, increasing risks of prehypertension (adjusted OR: 2.10, 95% CI 1.26 to 3.51) and hypertension (adjusted OR: 3.15, 95% CI 1.56 to 6.39) were observed in female participants with the fourth LAP quartile compared with those with the first one.

The results of ROC curve analysis in males and females were shown in [figures 1 and 2](#F1 F2){ref-type="fig"} and [table 5](#T5){ref-type="table"}. LAP (area under the curve (AUC)=0.721; 95% CI 0.680 to 0.761) was a better indicator to predict different types of hypertension than BMI (AUC=0.698; 95% CI 0.658 to 0.737), WHR (AUC=0.684; 95% CI 0.643 to 0.726) and TG (AUC=0.663; 95% CI 0.620 to 0.706) in females; however, WC (AUC=0.734; 95% CI 0.700 to 0.769) performed better than BMI (AUC=0.707; 95% CI 0.672 to 0.742), WHR (AUC=0.688; 95% CI 0.650 to 0.725), LAP (AUC=0.677; 95% CI 0.640 to 0.713) and TG (AUC=0.607; 95% CI 0.568 to 0.646) in males. The best cut-off values of LAP to predict hypertension were 63.892 in males and 30.860 in females.

![The receiver operating characteristic (ROC) curve of different obesity indexes in predicting hypertension in males. BMI, body mass index; LAP, lipid accumulation product; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio.](bmjopen-2019-029253f01){#F1}

![The receiver operating characteristic (ROC) curve of different obesity indexes in predicting hypertension in females. BMI, body mass index; LAP, lipid accumulation product; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio.](bmjopen-2019-029253f02){#F2}

###### 

Predicting hypertension by different obesity indexes

  Variables   Cut-off value   Sensitivity (%)   Specificity (%)   Youden index   AUC (95% CI)             P value
  ----------- --------------- ----------------- ----------------- -------------- ------------------------ ---------
  Male                                                                                                    
   BMI        23.004          73.51             58.08             0.316          0.707 (0.672 to 0.742)   \<0.001
   WHR        0.906           58.58             70.27             0.289          0.688 (0.650 to 0.725)   \<0.001
   LAP        63.892          49.63             76.99             0.266          0.677 (0.640 to 0.713)   \<0.001
   WC         85.05           65.67             72.60             0.383          0.734 (0.700 to 0.769)   \<0.001
   TG         1.91            46.27             70.14             0.164          0.607 (0.568 to 0.646)   \<0.001
  Female                                                                                                  
   BMI        21.767          81.58             50.73             0.323          0.698 (0.658 to 0.737)   \<0.001
   WHR        0.860           74.21             55.24             0.294          0.684 (0.643 to 0.726)   \<0.001
   LAP        30.860          68.95             67.42             0.363          0.721 (0.680 to 0.761)   \<0.001
   WC         79.90           72.11             64.94             0.370          0.725 (0.686 to 0.766)   \<0.001
   TG         1.26            63.68             64.49             0.282          0.663 (0.620 to 0.706)   \<0.001

AUC, area under the curve; BMI, body mass index; LAP, lipid accumulation product; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio.

Interaction effects between LAP and family history of hypertension {#s3-4}
------------------------------------------------------------------

The interaction effects between LAP and family history of hypertension were presented in [table 6](#T6){ref-type="table"}. Significant interaction effects between LAP and family history of hypertension were observed in males. The results of RERI (1.652; 95% CI 0.267 to 3.037) and AP (0.516; 95% CI 0.238 to 0.794) indicated a significant interaction effect of family history of hypertension and LAP on hypertension, but the result of SI (3.998; 95% CI 0.897 to 17.820) did not.

###### 

Interaction effects between LAP and family history of hypertension

  Variables   Variables         n     OR† (95% CI)                   Interaction indexes (95% CI)
  ----------- ----------------- ----- ------------------------------ -------------------------------
  Male                                                               
   LAP‡       Family history§                                        
   --         --                486   1 (reference)                  RERI=1.652 (0.267 to 3.037)\*
   --         \+                215   1.189 (0.772 to 1.832)         AP=0.516 (0.238 to 0.794)\*
   +          --                173   1.362 (0.875 to 2.121)         SI=3.998 (0.897 to 17.820)
   +          \+                128   3.203\*\*\* (2.002 to 5.124)   
  Female                                                             
   LAP‡       Family history§                                        
   --         --                657   1 (reference)                  RERI=−0.673 (−2.566 to 1.220)
   --         \+                276   1.995\*\* (1.284 to 3.099)     AP=−0.328 (−1.451 to 0.795)
   +          --                108   1.729\* (1.023 to 2.922)       SI=0.610 (0.125 to 2.979)
   +          \+                36    2.051 (0.919 to 4.589)         

\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.

†Adjusted for age, marital status, educational level, physical activity, smoker, drinker, body mass index (BMI) and waist-to-hip ratio (WHR).

‡Grouped by the cut-off values in [table 4](#T4){ref-type="table"}.

§Family history of hypertension was defined as one parent or both parents having hypertension.

AP, attributable proportion due to interaction;LAP, lipid accumulation product; RERI, relative excess risk of interaction ; SI, synergy index.

However, no statistically significant interaction effects were found between LAP and family history of hypertension in females, which was indicated by all the three indicators. RERI was −0.673 (95% CI −2.566 to 1.220); AP was −0.328 (95% CI −1.451 to 0.795); and SI was 0.610 (95% CI 0.125 to 2.979).

Discussion {#s4}
==========

With the rapid development of the economy and sedentary lifestyle, elevated BP has become a common and serious public health issue.[@R31] The prevalence of prehypertension and hypertension significantly increased.[@R32] Elevated BP is caused by diverse factors, among which obesity is closely related to hypertension.[@R33] The prevalence of obesity increased by 13% in urban areas and by 85% in rural areas in China, thus more attention should be paid to this issue.[@R17] Extensive studies found that obesity, especially visceral adipose tissue, could strongly increase the BP.[@R33]

The mechanisms underlying the interaction between obesity and hypertension are complicated. The mechanisms of obesity-induced hypertension include sodium retention, insulin resistance, activation of renin-angiotensin-aldosterone, altered vascular function and secretion of relevant adipokines.[@R34] Besides, the mechanisms of BP increase can be activated by visceral fat.[@R35]

Substantial evidence has shown that the harm of the fat accumulation is greater than the total amount of fat.[@R36] However, traditional obesity indexes, such as BMI, WC and WHR, have limitations of distinguishing differences between subcutaneous fat and visceral fat. Therefore, a new obesity index that can predict visceral fat easily and effectively is urgently needed. After Kahn has first shown that LAP performs better than BMI for recognising the cardiovascular risk, domestic and foreign scholars pay increasing attention to LAP. LAP, a combination of WC and TG, is an accessible and inexpensive way to assess visceral fat.[@R13] It is a well-known fact that TG reflects the degree of visceral fat accumulation and WC strongly associates with hypertension.[@R12] Notably, hypertriglyceridaemic waist (HTGW) is also calculated based on the combination of TG and WC. However, LAP, as a continuous indicator, is superior to reflect visceral fat than HTGW,[@R38] a discontinuous indicator.[@R21] Therefore, LAP is used as a visceral obesity indicator in this study.

LAP is based on the minimum WC which theoretically contains only the rachis, abdominal viscera and muscle.[@R13] Therefore, the differences between the actual WC and the minimum WC can represent abdominal adipose tissue.[@R13] Notably, LAP in almost all studies is calculated by data obtained based on the third National Health and Nutrition Examination Survey in the USA.[@R13] Because of differences in race, dietary habits or lifestyle, individuals from different countries should have different visceral adipose tissues. It is shown that there are considerable differences in visceral adipose tissues between Chinese individuals and Europeans or Americans.[@R39] Therefore, LAP is calculated in our study using a modified formula so that it could apply to the individuals dwelling in Southern China.

As expected, a significant association is found between LAP and hypertension in the present study. Our findings are consistent with those in studies by Zhong *et al*,[@R17] Song *et al* [@R37] and Shen *et al*,[@R22] all of which have demonstrated that LAP is an effective and reliable diagnostic indicator of hypertension. Participants with significantly higher LAP have higher risks of prehypertension and hypertension than those with lower LAP. Multinomial logistic regression analysis reveals that after adjusting for other factors, the risks of prehypertension and hypertension in the group with the highest LAP level are 2.10 and 3.15 times higher in females, respectively, than those in the group with the lowest LAP.

Wang *et al* found LAP is a better index to predict the risk of hypertension.[@R40] However, Gao *et al* found that the performance of LAP is superior to that of BMI in male Mongolians[@R23]; these findings may be due to the apparently lower prevalence of high TG in female Mongolians than in male Mongolians (13.20% vs 23.10%, p\<0.05), and the facts might disturb the association between LAP and hypertension in female Mongolians. Several studies find the superiority of LAP over BMI for detection of hypertension and prehypertension in both genders.[@R21] However, in the present study, we also found that LAP performs better than BMI in females. According to Kahn and Cheng,[@R41] the annual LAP changes are reduced at older age in males. Advancing age is associated with a progressive increase in systolic BP levels and with development and progression of arterial hypertension because of a number of factors, including atherosclerotic changes, large artery stiffening, altered renal function and arterial baroreflex impairment,[@R42] that is to say, increase in BP is thought to be an unavoidable consequence of ageing. Thus, the superiority of LAP for predicting hypertension in males may be disturbed by the larger scale proportion of elder men (23.7%) in our study. In our study, LAP performs better in predicting the hypertension risk than TG in both sexes. However, due to low predictive value of TG in Southern China, LAP, which combines TG and WC, is slightly inferior to WC.

In general, LAP, which applied to the Southern Chinese population, is a better indicator for predicting the hypertension risk in females in this study. In addition, large studies have demonstrated that family history of hypertension is a critical risk factor for hypertension, and individuals with family history of hypertension are two to four times more likely to develop hypertension than those without the family history of hypertension.[@R43] The interaction analysis in this study indicates the synergistic effect of LAP and family history on the hypertension risk in males, but no statistically significant differences in the interaction effect in females. These findings might be due to the fact that there was no statistically significant difference between females and the family history of hypertension in our study (χ^2^=6.847, p=0.0355\>0.05). In fact, cardiovascular events occur at a lower rate in females than in males.[@R44] In our study, the female participants who have both LAP and family history of hypertension are rarely observed and the prevalence rates of hypertension at a lower rate in females than in males no matter premenopausal status or menopausal status.[@R45] Our study suffers from a small sample size, especially in females. The fewer positive female observers who have higher LAP and family history of hypertension lead to no statistically significant differences in the interaction effect on the hypertension risk in females. The interaction in females is not statistically significant, but their synergistic effect is obvious. The synergistic effect between family history of hypertension and LAP on the hypertension risk is demonstrated in our study as well as in other studies.[@R21] Visceral obesity and family history of hypertension may result in increased BP through some unknown mechanisms. However, further studies are needed to investigate the interaction effect between LAP and family history of hypertension on the hypertension risk.

To date, LAP is an inexpensive screening tool to identify visceral adipose tissue, and the method has high reproducibility. LAP, which is proposed by Kahn, is developed for the Western population. Thus this study explored the validity of LAP, which is calculated based on the Southern Chinese population, and the interactive effects of LAP and family history of hypertension. The findings suggest LAP might perform better in predicting the hypertension risk than BMI, WHR and TG in Southern Chinese females. Furthermore, the interaction analysis in this study indicates the synergistic effect of LAP and family history on the hypertension risk. Although the interaction in females is not statistically significant, their synergistic effect is obvious.

This study has some limitations. First of all, because this is a cross-sectional study, the present results are not sufficient to indicate causality. Second, the population of our study can partially represent the general population in the Southern China, but cannot fully represent this region. Furthermore, this article lacks adjustment for renal function, and other risk factors for hypertension (such as serum uric acid). Finally, because of the small sample size in this study, further studies with a larger sample size are needed to investigate whether the modified LAP applies to all the residents dwelling in Southern China.

Conclusion {#s5}
==========

In conclusion, LAP significantly associates with the hypertension risk, and higher LAP levels have relatively higher BP. It has better performance than BMI, WHR and TG on predicting hypertension risk of the Southern Chinese female population. Moreover, LAP and family history of hypertension might synergistically increase the risk of hypertension.
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